Therapeutic Effects of Human Umbilical Cord Blood Cells on Neuronal Hypoxia
Author Information
Author(s): Doreen M. Reich, Susann Hau, Tobias Stahl, Markus Scholz, Wilfried Naumann, Frank Emmrich, Johannes Boltze, Manja Kamprad
Primary Institution: Fraunhofer-Institute for Cell Therapy and Immunology
Hypothesis
Can human umbilical cord blood mononuclear cells (HUCB-MNC) and their stem cell fractions reduce neuronal apoptosis in a hypoxic environment?
Conclusion
The study found that both total HUCB-MNC and CD133-depleted fractions can significantly reduce neuronal apoptosis and help maintain neuronal characteristics.
Supporting Evidence
- Direct co-cultivation with HUCB-MNC reduced neuronal apoptosis significantly.
- CD133- cells produced high concentrations of neuroprotective factors.
- Untreated post-hypoxic control cultures showed high apoptosis rates of 85% ± 11%.
Takeaway
Researchers tested if special cells from umbilical cord blood could help brain cells survive when they are not getting enough oxygen, and they found that these cells can really help.
Methodology
The study used an in vitro model of neuronal hypoxia with different fractions of HUCB-MNC to analyze their effects on neuronal cell apoptosis and necrosis.
Limitations
The in vitro model may not fully represent the complex interactions in vivo after hypoxic brain lesions.
Statistical Information
P-Value
p ≤ 0.001
Statistical Significance
p ≤ 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website